Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Efficacy and safety of adding clopidogrel to aspirin on stroke prevention among high vascular risk patients: a meta-analysis of randomized controlled trials.

Chen S, Shen Q, Tang Y, He L, Li Y, Li H, Li M, Peng Y.

PLoS One. 2014 Aug 11;9(8):e104402. doi: 10.1371/journal.pone.0104402. eCollection 2014.

2.

Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.

Zhang Q, Wang C, Zheng M, Li Y, Li J, Zhang L, Shang X, Yan C.

Cerebrovasc Dis. 2015;39(1):13-22. doi: 10.1159/000369778. Epub 2014 Dec 24. Review. Erratum in: Cerebrovasc Dis. 2015;39(3-4):249-51.

3.

Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis.

Tan S, Xiao X, Ma H, Zhang Z, Chen J, Ding L, Yu S, Xu R, Yang S, Huang X, Hong H.

PLoS One. 2015 Aug 13;10(8):e0135372. doi: 10.1371/journal.pone.0135372. eCollection 2015. Review.

4.

Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis.

Malloy RJ, Kanaan AO, Silva MA, Donovan JL.

Clin Ther. 2013 Oct;35(10):1490-1500.e7. doi: 10.1016/j.clinthera.2013.09.004.

PMID:
24139421
5.
6.

Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis.

Katsanos K, Spiliopoulos S, Saha P, Diamantopoulos A, Karunanithy N, Krokidis M, Modarai B, Karnabatidis D.

PLoS One. 2015 Aug 14;10(8):e0135692. doi: 10.1371/journal.pone.0135692. eCollection 2015. Review.

7.

Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.

Gouya G, Arrich J, Wolzt M, Huber K, Verheugt FW, Gurbel PA, Pirker-Kees A, Siller-Matula JM.

Stroke. 2014 Feb;45(2):492-503. doi: 10.1161/STROKEAHA.113.002590. Epub 2013 Dec 24. Review.

8.

Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events.

Bowry AD, Brookhart MA, Choudhry NK.

Am J Cardiol. 2008 Apr 1;101(7):960-6. doi: 10.1016/j.amjcard.2007.11.057. Epub 2008 Feb 11. Review.

PMID:
18359315
9.

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Cochrane Database Syst Rev. 2003;(1):CD001820. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD001820.

PMID:
12535415
10.

Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.

Lee M, Saver JL, Hong KS, Rao NM, Wu YL, Ovbiagele B.

Ann Intern Med. 2013 Oct 1;159(7):463-70. doi: 10.7326/0003-4819-159-7-201310010-00006. Review.

PMID:
24081287
11.

Effect of addition of clopidogrel to aspirin on stroke incidence: Meta-analysis of randomized trials.

Palacio S, Hart RG, Pearce LA, Anderson DC, Sharma M, Birnbaum LA, Benavente OR.

Int J Stroke. 2015 Jul;10(5):686-91. doi: 10.1111/ijs.12050. Epub 2013 May 22.

12.
13.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

14.

Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.

Niu PP, Guo ZN, Jin H, Xing YQ, Yang Y.

BMJ Open. 2016 Mar 17;6(3):e009013. doi: 10.1136/bmjopen-2015-009013. Review.

15.

Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.

Bedenis R, Lethaby A, Maxwell H, Acosta S, Prins MH.

Cochrane Database Syst Rev. 2015 Feb 19;(2):CD000535. doi: 10.1002/14651858.CD000535.pub3. Review.

PMID:
25695213
16.

Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.

Udell JA, Bonaca MP, Collet JP, Lincoff AM, Kereiakes DJ, Costa F, Lee CW, Mauri L, Valgimigli M, Park SJ, Montalescot G, Sabatine MS, Braunwald E, Bhatt DL.

Eur Heart J. 2016 Jan 21;37(4):390-9. doi: 10.1093/eurheartj/ehv443. Epub 2015 Aug 31. Review.

PMID:
26324537
17.
18.

Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials.

Geeganage CM, Diener HC, Algra A, Chen C, Topol EJ, Dengler R, Markus HS, Bath MW, Bath PM; Acute Antiplatelet Stroke Trialists Collaboration..

Stroke. 2012 Apr;43(4):1058-66. doi: 10.1161/STROKEAHA.111.637686. Epub 2012 Jan 26. Review.

19.

Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.

Shantsila E, Lip GY.

Cochrane Database Syst Rev. 2016 Sep 15;9:CD003333. [Epub ahead of print] Review.

PMID:
27629776
20.

Effects of combined aspirin and clopidogrel therapy on cardiovascular outcomes: a systematic review and meta-analysis.

Zhou YH, Wei X, Lu J, Ye XF, Wu MJ, Xu JF, Qin YY, He J.

PLoS One. 2012;7(2):e31642. doi: 10.1371/journal.pone.0031642. Epub 2012 Feb 13.

Supplemental Content

Support Center